Cargando…

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis

Background: Cardiac amyloidosis is an increasingly recognized etiology of heart failure, in part due to the rise of non-invasive nuclear bone scintigraphy. Molecular imaging using positron emission tomography (PET) has promised the direct visualization of cardiac amyloid fibrils. We sought to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sperry, Brett W., Bock, Ashley, DiFilippo, Frank P., Donnelly, Joseph P., Hanna, Mazen, Jaber, Wael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267881/ https://www.ncbi.nlm.nih.gov/pubmed/34250046 http://dx.doi.org/10.3389/fcvm.2021.693194

Ejemplares similares

A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir
por: Osborne, Dustin R., et al.
Publicado: (2015)

Conversion of (99m)technetium-pyrophosphate scintigraphy in a patient with hereditary ATTR amyloidosis: importance of repeat scanning
por: Hussain, Muzna, et al.
Publicado: (2020)

Radiation dosimetry of florbetapir F 18
por: Joshi, Abhinay D, et al.
Publicado: (2014)

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds
por: Wagner, T., et al.
Publicado: (2018)

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review
por: Hartnett, Jack, et al.
Publicado: (2021)

Dual-phase [18F]florbetapir in frontotemporal dementia
por: Asghar, Michael, et al.
Publicado: (2018)

[18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study
por: Dupont, Anne-Claire, et al.
Publicado: (2015)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Subtype‐Specific Interactions and Prognosis in Cardiac Amyloidosis
por: Sperry, Brett W., et al.
Publicado: (2016)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Atypical Case of Wild-Type Cardiac Amyloidosis with Septal Predominance and a Nonapical Sparing Strain Pattern
por: Hussain, Muzna, et al.
Publicado: (2021)

[(18)F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Operationalizing the centiloid scale for [(18)F]florbetapir PET studies on PET/MRI
por: Coath, William, et al.
Publicado: (2023)

Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
por: Itani, Malak, et al.
Publicado: (2017)

Quantification of [(18)F]florbetapir: A test–retest tracer kinetic modelling study
por: Golla, Sandeep SV, et al.
Publicado: (2018)

(18)F-florbetapir PET/MRI for quantitatively monitoring demyelination and remyelination in acute disseminated encephalomyelitis
por: Zhang, Min, et al.
Publicado: (2019)

(18)F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
por: Moscoso, Alexis, et al.
Publicado: (2021)

Hybrid (18)F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients
por: Meng, Huanyu, et al.
Publicado: (2022)

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
por: Doraiswamy, P M, et al.
Publicado: (2014)

Using PET with (18)F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
por: Camus, V., et al.
Publicado: (2012)

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment
por: Shokouhi, Sepideh, et al.
Publicado: (2016)

Fulminant cardiac amyloidosis
por: Real, Carlos, et al.
Publicado: (2021)

PET imaging of 18F-florbetapir in cognitively impaired individuals: Lack of activity within the cerebellar cortex
por: Meyer, Michael A., et al.
Publicado: (2018)

Tracer‐specific reference tissues selection improves detection of (18)F‐FDG, (18)F‐florbetapir, and (18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022)

Cardiac sarcoidosis mimics cardiac amyloidosis in an elderly patient
por: Kafil, Tahir S, et al.
Publicado: (2022)

Subthreshold Aortic Valve Calcium Scores in Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis
por: Hussain, Muzna, et al.
Publicado: (2020)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [(18)F]Flortaucipir and [(18)F]Florbetapir Brain PET Studies
por: de Vries, Bart M., et al.
Publicado: (2021)

Application of Haralick texture features in brain [(18)F]-florbetapir positron emission tomography without reference region normalization
por: Campbell, Desmond L, et al.
Publicado: (2017)

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
por: Lilleker, James B, et al.
Publicado: (2019)

Repeatability of parametric methods for [(18)F]florbetapir imaging in Alzheimer’s disease and healthy controls: A test–retest study
por: Verfaillie, Sander CJ, et al.
Publicado: (2020)

Computational approaches to detect small lesions in (18)F‐FDG PET/CT scans
por: Nichols, Kenneth J., et al.
Publicado: (2021)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Spontaneous intramyocardial haematoma in transthyretin cardiac amyloidosis
por: Parizher, Gary, et al.
Publicado: (2022)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders
por: Siderowf, Andrew, et al.
Publicado: (2014)

Head-to-head comparison of relative cerebral blood flow derived from dynamic [(18)F]florbetapir and [(18)F]flortaucipir PET in subjects with subjective cognitive decline
por: Tuncel, Hayel, et al.
Publicado: (2023)

Spill-in counts in the quantification of (18)F-florbetapir on Aβ-negative subjects: the effect of including white matter in the reference region
por: López-González, Francisco Javier, et al.
Publicado: (2019)

(18)F-florbetapir PET/MRI for quantitatively monitoring myelin loss and recovery in patients with multiple sclerosis: A longitudinal study
por: Zhang, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8almces1numm87g5fjn3kmundg